Lawsuit Claims Two Iron Injections of Injectafer Caused Woman’s Phosphate Levels Dropped to Critically Low Levels
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Iron Deficiency Infusion Lawsuit Filed Against Injectafer Manufacturers Injectafer manufacturers failed to disclose the potential adverse health risks for years, according to the iron deficiency infusion lawsuit. February 6, 2023 Irvin Jackson Add Your Comments A Florida woman has filed a product liability lawsuit against the makers of the iron deficiency infusion Injectafer, indicating that she suffered dangerous drops in her phosphate blood levels following two injections, which left her with permanent and disabling injuries. The complaint (PDF) was filed by Shannon Murray on January 31 in the U.S. District Court for the Eastern District of Pennsylvania, presenting claims against Luitpold Pharmaceuticals, American Regent, Inc., Daiichi Sankyo, Inc. and Vifor International AG as the defendants. Injectafer (ferric carboxymaltose) has been marketed as a safe and effective iron deficiency infusion treatment since 2013, which is typically administered to adults experiencing anemia, who are not able to manage the condition with an oral iron supplement or have non-dialysis dependent chronic kidney disease. However, in recent years several hundred similar Injectafer lawsuits have been filed in courts nationwide, each raising similar allegations indicating drug makers knew or should have known about the risks of dangerous decreases in blood phosphate levels, which can lead to the development of severe and symptomatic hypophosphatemia (HPP) and leave patients with muscle weakness, joint and bone pain, fatigue, difficulty walking and other long-term health complications. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Murray indicates she suffered from iron deficiency anemia (IDA) and received two Injectafer infusions in April 2018, with the injections only a few days apart. “Subsequent to Plaintiff’s Injectafer use, she suffered symptoms indicative of severe and/or symptomatic hypophosphatemia,” her lawsuit states. “As a result of her use of Injectafer, Plaintiff has suffered, and will likely suffer in the future, severe and permanent injuries and damages, including, but not limited to: severe muscle and joint pain, paresthesias, headaches, nausea and vomiting, muscle and bone stiffness, limited range of motion, dizziness, stress and anxiety.” When the drug was first introduced in 2013, the Injectafer warning label described reports of serum phosphate drops as “asymptomatic” or “transient.” In 2018, that warning was upgraded, but only suggested hypophosphatemia side effects were mild and infrequent. It was not until February 2020 that the warnings about Injectafer side effects (PDF) were updated to add more detailed information about the risk of symptomatic hypophosphatemia caused by the iron infusion. However, critics have said even those warnings remain inadequate. Because of the manufacturers’ misleading actions in failing to adequately disclose the risks of their iron deficiency infusion drug, there was no way for Murray to know her illnesses were connected the Injectafer injections, according to the lawsuit. 2023 Injectafer Lawsuit Update Several hundred claims over side effects of Injectafer iron deficiency infusions have been filed throughout the federal court system, which are all pending in the U.S. District Court for the Eastern District of Pennsylvania. Since each of the claims raise similar questions of fact and law, the Court is preparing a group of representative cases for early trial dates, to help gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation. Last year, the U.S. District Judge presiding over the litigation indicated that the first Injectafer lawsuit will go before a jury in June 2023, involving a complaint brought by Katherine Crockett, who developed severe pain and fatigue after a series of two iron deficiency infusions in May 2017. In December 2022, an order (PDF) was issued scheduling two other cases for early trial dates, which are expected to begin on October 2, 2023 and November 29, 2023. While the outcome of these early trial dates will not be binding on lawsuits filed by Murray and other plaintiffs, the average Injectafer lawsuit payouts awarded may have a substantial impact on any iron deficiency infusion settlements the manufacturer may offer to avoid the need for each case to go before a jury in the federal court system. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Anemia, Anemia Drug, Daiichi Sankyo, Hypophosphatemia, Injectafer, Iron Deficiency More Injectafer Lawsuit Stories Injectafer Fails to Prevent Heart Failure in Patients with Iron Deficiency, Study Finds August 29, 2023 Four Injectafer Lawsuits To Go Before Juries For Trial Dates Set to Begin in 2023 February 20, 2023 Lawsuit Claims Two Iron Injections of Injectafer Caused Woman’s Phosphate Levels Dropped to Critically Low Levels January 13, 2023 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: today) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUIT Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Injectafer Fails to Prevent Heart Failure in Patients with Iron Deficiency, Study Finds August 29, 2023
Lawsuit Claims Two Iron Injections of Injectafer Caused Woman’s Phosphate Levels Dropped to Critically Low Levels January 13, 2023
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: today) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUIT
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)